Susanna Hallberg

Artiklar

Article: LANCET NEUROLOGY. 2022;21(8):693-703
Safety and efficacy of rituximab versus dimethyl fumarate in patients with relapsing-remitting multiple sclerosis or clinically isolated syndrome in Sweden: a rater-blinded, phase 3, randomised controlled trial
Svenningsson A; Frisell T; Burman J; Salzer J; Fink K; Hallberg S; Hambraeus J; Axelsson M; Al Nimer F; Sundstrom P; Gunnarsson M; Johansson R; Mellergard J; Rosenstein I; Ayad A; Sjoblom I; Risedal A; de Flon P; Gilland E; Lindeberg J; Shawket F; Piehl F; Lycke J

Doktorand, Kliniska vetenskaper, Danderyds sjukhus, Karolinska Institutet, 2025-2028

Research School for Clinicians in Epidemiology 2019-2021, Epidemiology, KEP, Karolinska Institutet, 2019
Läkarexamen, Karolinska Institutet, 2002